Drug profile · INN
voretigene neparvovec
LUXTURNA
voretigene neparvovec (LUXTURNA) is a retinoid isomerohydrolase exogenous gene.
EMA: approved Sensory organs (S01) S01XA27
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — voretigene neparvovec
- Class
- Sensory organs (S01)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
voretigene neparvovec (LUXTURNA) is a retinoid isomerohydrolase exogenous gene.
Key facts
INN voretigene neparvovec
Brand LUXTURNA
Mechanism Retinoid isomerohydrolase exogenous gene
Target Retinoid isomerohydrolase
Therapeutic class Sensory organs (S01)
ATC code S01XA27
Mechanism of action
Retinoid isomerohydrolase exogenous gene
Primary target: Retinoid isomerohydrolase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is voretigene neparvovec?
voretigene neparvovec (LUXTURNA) is a retinoid isomerohydrolase exogenous gene.
What is the brand name for voretigene neparvovec?
LUXTURNA is a marketed brand name for voretigene neparvovec. Check FDA Drugs@FDA for the current US label holder and prescribing information.